Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Februar 2013 10:07 ET | Quelle: Nanosphere, Inc.

Nanosphere to Release Q4 and Full Year 2012 Results and Hold Investor Call on Wednesday, February 13

NORTHBROOK, Ill., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its results...
10. Dezember 2012 15:26 ET | Quelle: Nanosphere, Inc.

Nanosphere Receives FDA Clearance for C. difficile Test

Comprehensive sample-to-result test detects potentially deadly C. difficile and identifies 027 hypervirulent strain Expands menu of infectious disease tests on Verigene®...
29. November 2012 09:47 ET | Quelle: Nanosphere, Inc.

Nanosphere to Present at Canaccord Genuity Medical Technology & Diagnostics Forum

NORTHBROOK, Ill., Nov. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
21. November 2012 10:51 ET | Quelle: Nanosphere, Inc.

Nanosphere to Present at Piper Jaffray 24th Annual Healthcare Conference

NORTHBROOK, Ill., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
13. November 2012 07:45 ET | Quelle: Nanosphere, Inc.

Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism

NORTHBROOK, Ill., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today the US...
07. November 2012 16:01 ET | Quelle: Nanosphere, Inc.

Nanosphere Announces Third Quarter 2012 Results

50 new VerigeneSP system placements double over prior quarter C. difficile assay filed with FDA FDA categorizes blood stream gram-positive test as CLIA moderate complexity NORTHBROOK,...
06. November 2012 09:29 ET | Quelle: Nanosphere, Inc.

Nanosphere to Present at Lazard Capital Markets and Stephens Inc. Investor Conferences

NORTHBROOK, Ill., Nov. 6, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William...
01. November 2012 18:20 ET | Quelle: Nanosphere, Inc.

Nanosphere's Bloodstream Infection Test Designated Moderate Complexity by FDA

NORTHBROOK, Ill., Nov. 1, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today that it...
26. Oktober 2012 10:43 ET | Quelle: Nanosphere, Inc.

Nanosphere to Release Q3 2012 Results and Hold Investor Call on Wednesday, November 7

NORTHBROOK, Ill., Oct. 26, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, will report its...
22. Oktober 2012 10:29 ET | Quelle: Nanosphere, Inc.

Nanosphere Test Accurately Detects a Broad Panel of Bacterial Targets and Resistance Determinants Directly From Blood Culture

NORTHBROOK, Ill., Oct. 22, 2012 (GLOBE NEWSWIRE) -- Nanosphere's (Nasdaq:NSPH) Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) (IUO), based on the company's proprietary array-based...

Vorherige Seite